IRulya Therapeutics Inc. vs EyePoint Pharmaceuticals, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- IRulya Therapeutics Inc. and EyePoint Pharmaceuticals, Inc. are worth about the same: $343 M and $349 M (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 14, 2026 for EyePoint Pharmaceuticals, Inc.).
- Both made a net loss: $84 M for IRulya Therapeutics Inc. and $232 M for EyePoint Pharmaceuticals, Inc.
- EyePoint Pharmaceuticals, Inc. employs more people: 123 against 55 at IRulya Therapeutics Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | IRulya Therapeutics Inc. IRLA · #14,187 in the world | EyePoint Pharmaceuticals, Inc. EYPT · #14,107 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 1987 |
| Size | ||
| Market cap | $343 M | $349 M |
| Revenue | — | $31 M |
| Net income | $-84 M▲ best | $-232 M |
| Employees | 55 | 123 |
| Valuation | ||
| Price to sales | — | 11.1× |
| Price to book | — | 1.1× |
| Free cash flow yield | -12.2%▲ best | -69.7% |
| Profitability | ||
| Operating margin | — | -776.0% |
| Net margin | — | -739.4% |
| Return on equity | — | -72.2% |
| Growth | ||
| Revenue growth | — | -27.5% |
| Revenue growth, 3 years a year | — | -8.8% |
| Cash | ||
| Free cash flow margin | — | -775.9% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, IRulya Therapeutics Inc. or EyePoint Pharmaceuticals, Inc.?
IRulya Therapeutics Inc. and EyePoint Pharmaceuticals, Inc. are worth about the same: $343 M and $349 M (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 14, 2026 for EyePoint Pharmaceuticals, Inc.).
Which makes more money, IRulya Therapeutics Inc. or EyePoint Pharmaceuticals, Inc.?
Both made a net loss: $84 M for IRulya Therapeutics Inc. and $232 M for EyePoint Pharmaceuticals, Inc.
Which has more employees, IRulya Therapeutics Inc. or EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. employs more people: 123 against 55 at IRulya Therapeutics Inc.
More about IRulya Therapeutics Inc.
More about EyePoint Pharmaceuticals, Inc.
- EyePoint Pharmaceuticals, Inc.: company page
- Who owns EyePoint Pharmaceuticals, Inc.?
- EyePoint Pharmaceuticals, Inc. market cap history
- EyePoint Pharmaceuticals, Inc. revenue by year
- How many employees does EyePoint Pharmaceuticals, Inc. have?
- Is EyePoint Pharmaceuticals, Inc. cheap or expensive?
- EyePoint Pharmaceuticals, Inc. against its peers: ranks and percentiles